ライフサイエンスコーパス: smear

1 HWs were also taught to obtain a thick blood smear.

2 n than the standard sputum acid-fast bacilli smear.

3 tomography (HRCT) and the results of sputum smear.

4 tting tuberculosis and is superior to sputum smear.

5 had significant association with a negative smear.

6 the low sensitivity and specificity of blood smears.

7 l specimens including Papanicolaou and blood smears.

8 ed by positive results of acid-fast bacillus smears.

9 smear preparation, and interpretation of the smears.

10 e majority of the missed cases had low-grade smears.

11 nary tuberculosis is guided by serial sputum smears.

12 tudy because they were studied by impression smears.

13 tive acid-fast bacilli (%LB + AFB) on sputum smears.

14 re tested for microfilaraemia by night blood smears.

15 s, and the glass and the jamming regimes are smeared.

16 ry of a cervical procedure to treat abnormal smears]).

17 onding red blood cell pellets, including 185 smears (50.4%) that were positive by microscopy.

18 37.4 to 59.6) was lower than those of direct smear (60.9%; 51.4 to 70.5 [P = 0.0001]) and concentrate

19 51.4 to 70.5 [P = 0.0001]) and concentrated smear (63.3%; 53.6 to 73.1 [P < 0.0001]).

20 All DS neonates had multiple blood count and smear abnormalities.

21 se in the highest grade of acid-fast bacilli smear (AFS).

22 -8% to 45%]) among those who had >/= one Pap smear after enrollment.

23 By contrast, the Fe distribution is smeared along an arc corresponding to the proposed path

24 0% of infections that were detected by blood smear analysis (14/14) and broadened the detection windo

25 verage increases from 81.3% accuracy without smear analysis to 93.9% with smear characterization and

26 kettsial morulae were detected on peripheral smear and bone marrow biopsy specimens, and PCR amplifie

27 We also extracted data on the smear and culture status of index cases, the age and bac

28 nfection is typically accomplished by fungal smear and culture, histopathologic examination, and/or s

29 each evaluated with acid-fast bacilli (AFB) smear and mycobacterial culture using liquid and solid c

30 species diagnosis was based on a thin blood smear and/or a quick diagnostic test.

31 g the probed volume, which introduces signal smearing and precludes the scanning of complex structure

32 ess of this approach by imaging Papanicolaou smears and breast cancer tissue slides over a large fiel

33 We extracted DNA from archived blood smears and corresponding red blood cell pellets collecte

34 We analyzed a total of 367 blood smears and corresponding red blood cell pellets, includi

35 We evaluated induced sputum Gram stain smears and cultures from hospitalized children aged 1-59

36 Corneal smears and cultures were obtained from all study partici

37 Thick blood smears and RDTs were usually taken at hospital admission

38 sted extensively using both peripheral blood smears and renal glomeruli specimens.

39 reased as evidenced by schistocytes on blood smears and shortened red blood cell lifespan.

40 (390,310 first abnormal and 1,951,319 normal smears) and in situ/invasive cervical cancer (75,128 cas

41 ticipant received a vaginal examination, PAP smear, and completed a questionnaire.

42 lar junctions are maintained is a measure of smear, and the resulting variance in unbiased single mea

43 and specificity were estimated for SMF, AFB smear, and Xpert MTB/RIF, using MGIT as the reference st

44 ing in the clinic for a routine Papanicolaou smear, and/or women seeking a routine gynecologic checku

45 ethods (flow cytometry, examination of blood smears, and T cell receptor gene rearrangements), and pe

46 n diagnosing pulmonary TB cases whose sputum smears are negative and making a correlation between the

47 uspected of having active pulmonary TB whose smears are negative can benefit from MD HRCT chest findi

48 Tissue smears are shown to give the same chemical information a

49 des of malaria diagnosed with positive thick smear) at age 4 years.

50 teins in the lactose excipient and found the smear band by silver staining, which was identified as b

51 al of 1 650 961 (51.4%) were screened by the smear-based algorithm and 1 561 460 (48.6%) were screene

52 tes were screened for tuberculosis (TB) by a smear-based algorithm that could not diagnose smear-nega

53 roving referrals from informal providers for smear-based diagnosis in the public sector (without Xper

54 antly reduced AII duration compared with the smear-based strategy.

55 nd sectioning, which we address by analyzing smeared biopsy tissue.

56 diagnosis is Giemsa stained peripheral blood smear but false negative findings are always reported.

57 c predicted increased risk of positive blood smear but, interestingly, decreased risk of symptomatic

58 culations indicate that the Fermi surface is smeared by the disorder due to the presence of vacancies

59 try (DESI-MS) is used to characterize tissue smears by comparison with a library of DESI mass spectra

60 strate how binning measurements according to smear can significantly enhance the use of individual co

61 Therefore, blood smears can provide an adequate source of DNA for confirm

62 ccuracy without smear analysis to 93.9% with smear characterization and binning (SCRIB).

63 Direct smear collected from sputum or gastric lavage, as well a

64 25.9% of specimens tested positive by direct smear, concentrated smear, MGIT culture, LJ culture, and

65 eneity was reduced for culture-confirmed and smear-confirmed cases.

66 ica many falciparum-infected persons without smear-detectable gametocytes still infect mosquitoes.

67 The 8.4% of patients with smear-detectable gametocytes were >20 times more likely

68 abdominal ultrasound, whole-blood counts and smears, determinations of plasma immunoglobulin and comp

69 Compared to microscopy, PCR-HRM analysis of smear DNA had a sensitivity of 93.0% (95% confidence int

70 In these measurements, "smearing" due to conformational changes and other entrop

71 were found in one-half of the margin biopsy smears, even in cases where postoperative MRI suggested

72 We collected blood smears every 2 weeks and during any illness for 24 weeks

73 Intraoperative DESI-MS analysis of tissue smears, ex vivo, can be inserted into the current surgic

74 xamination findings, anal Papanicolaou (Pap) smear findings.

75 culture-confirmed cases, and yield of sputum smear for acid-fast bacilli cases.

76 esiosis, with no parasites detected on blood smear for at least the final 2 weeks of treatment.

77 intraoperative DESI-MS evaluation of tissue smears for rapid diagnosis.

78 croscopy on routine scan of peripheral blood smears for red blood cell morphology.

79 d the use of DNA extracts from stained blood smears for the detection of Plasmodium species using rea

80 as confirmed in Giemsa-reagent stained blood smears for the Type I sample.

81 ng Register (1969-2011) including 14,011,269 smears from 2,466,107 women, we conducted two nested cas

82 length in genomic DNA extracted from buccal smears from 63 patients with BD, 74 first-degree relativ

83 say into both cancer cell lines and cervical smears from patients.

84 socio-economic status, and index case sputum smear grade, the hazard ratio for tuberculosis disease a

85 sult in only 1 of 3 samples, and 5 had a low smear grade.

86 s levels had a positive correlation with the smear grades, and the individual sample-positive/pooled

87 than with Hain V1 and V2 in samples with low smear grades.

88 cterial burden using cycle threshold values, smear grading, and time to culture positivity.

89 The negative smear group featured lymphadenopathy, consolidation, col

90 ost primary tuberculosis, while the negative smear group most often manifested with primary tuberculo

91 most prevalent abnormalities in the positive smear group were consolidation, tree-in-bud pattern, upp

92 nd determined the failure rate of Gram stain smears (GSS) due to insufficient cellular material.

93 terial morphotypes of a Gram-stained vaginal smear (i.e., Nugent scoring).

94 lso observed in aerosol samples collected at SMEAR II station (Hyytiala, Finland) in August 2015 sugg

95 ed in aerosol samples (PM1) collected at the SMEAR II station (Hyytiala, Finland) suggesting that DMA

96 Malaria was identified by blood smear in 10 of 18 patients (56%) on admission, and by ra

97 ariae speciation was correctly identified by smear in 2 of 18 (11%) patients.

98 ulture in the nose and cytology in the nasal smear in asymptomatic (PreAs), symptomatic in pre-season

99 Here, we show a method for characterizing smear in single-molecule conductance measurements and de

100 a methodology to unveil the signals that are smeared in the strong ambient noise and thus facilitate

101 These were correlated to blood counts and smears in a subset of patients.

102 opic examination of acid-fast-stained sputum smears is the current standard of care in the United Sta

103 gnosis of malaria using Giemsa-stained blood smears is the standard of care in resource-limited setti

104 four time periods with a fluxmeter: 1) with smear layer, 2) after 37% phosphoric acid etching, 3) af

105 cleotide recognition when only low molecular smear measurements are used, which represents a signific

106 ested positive by direct smear, concentrated smear, MGIT culture, LJ culture, and Xpert test, respect

107 , 2012, we randomly assigned 758 patients to smear microscopy (182 culture positive) and 744 to Xpert

108 toms, obtained one induced sputum sample for smear microscopy (AFB) and mycobacterial culture, and pe

109 ntaneously expectorated sputum specimens for smear microscopy (direct, concentrated, and SMF), MGIT (

110 Samples were processed by corneal smear microscopy (potassium hydroxide with calcofluor wh

111 test for tuberculosis, compared with sputum smear microscopy (the standard of care).

112 cost than conventional strategy with sputum smear microscopy (US$ 119 million/year).

113 microscopy laboratories compared with using smear microscopy against a reference standard of solid a

114 Serial sputum smear microscopy and a single concentrated sputum Xpert

115 No difference was observed between smear microscopy and Xpert in sensitivity or specificity

116 We performed smear microscopy and Xpert testing on concentrated sputu

117 Smear microscopy and Xpert were performed on each sputum

118 76 clinical samples (56 positives using thin smear microscopy as the reference method and 20 negative

119 m falciparum infection was assessed by blood smear microscopy at all visits.

120 s (interquartile range [IQR], 47.1-97.5) for smear microscopy compared with 20.8 hours (IQR, 16.8-32.

121 he correlation of cycle threshold values and smear microscopy grade with time to culture positivity.

122 tween groups at 2 months (2 [IQR 0-3] in the smear microscopy group vs 2 [0.25-3] in the MTB/RIF grou

123 In South Africa, sputum smear microscopy has been replaced with Xpert MTB/RIF as

124 Sputum acid-fast bacilli (AFB) smear microscopy has suboptimal sensitivity but remains

125 Smear microscopy has suboptimal sensitivity, and there i

126 Sputum smear microscopy is associated with considerable variabi

127 lts of serial sputum acid-fast bacilli (AFB) smear microscopy is standard practice in high-income cou

128 l to equal culture's sensitivity with sputum smear microscopy negative specimens and therefore cannot

129 ne infection isolation (AII) and assessed by smear microscopy on 3 respiratory specimens collected 8-

130 ended by the World Health Organization for a smear microscopy replacement tuberculosis test.

131 The study utilized smear microscopy slides prepared from sputum specimens s

132 The 2- and 3-specimen Xpert and smear microscopy strategies captured all 6 tuberculosis

133 he point-of-care by the Ziehl-Neelsen sputum smear microscopy test.

134 Median laboratory processing time for smear microscopy was 2.5 times as long as Xpert (P < .00

135 sis case detection of Gene drive, Xpert, and smear microscopy were 45.4% (95% confidence interval [CI

136 The sensitivities of culture, Xpert, and smear microscopy were estimated to be 60% (95% CrI: 46,

137 Replacing serial sputum smear microscopy with a single sputum Xpert could elimin

138 mens were collected and tested by GeneXpert, smear microscopy, and culture.

139 a were tested by Xpert MTB/RIF, concentrated smear microscopy, and liquid culture to quantify bacteri

140 collection of specimens, low sensitivity of smear microscopy, and poor access to culture.

141 ected from each inpatient and analyzed using smear microscopy, culture, drug susceptibility testing,

142 h pulmonary tuberculosis confirmed by sputum smear microscopy, culture, or both; MDR or XDR tuberculo

143 imen tested with Direct LPA, MTBDR-Plus LPA, smear microscopy, MGIT, biochemical identification of my

144 were processed in parallel with conventional smear microscopy, TBDx microscopy, and liquid culture.

145 wing tests were used: mycobacterial culture, smear microscopy, Xpert MTB/RIF (Cepheid Inc.), tubercul

146 hat are negative for acid-fast bacilli using smear microscopy.

147 ith 1 or more sputum specimens submitted for smear microscopy.

148 formed Xpert MTB/RIF at the clinic or sputum smear microscopy.

149 comparable to the gold standard of the blood smear microscopy.

150 more specific, and more cost-effective than smear microscopy.

151 eir speed and sensitivity compared to sputum smear microscopy.

152 of Gene drive and Xpert for the detection of smear-microscopy-negative tuberculosis were 0% (95% CI,

153 uded (1) a sputum-based replacement test for smear-microscopy; (2) a non-sputum-based biomarker test

154 o demonstrated that children with a positive smear most likely presented with radiological features o

155 Patients with smear negative disease and age </=10 years were less lik

156 esent in 34% of samples, and 25% were sputum smear negative.

157 ear-positive [AFB(+)] sputum, 59.3% with AFB smear-negative [AFB(-)] sputum), specificity of 99.2%, n

158 respectively, for the 137 participants with smear-negative and culture-positive sputum (difference o

159 In the new smear-negative and MDR TB cascades, a substantial propor

160 n India's TB cascade of care, especially for smear-negative and MDR TB patients.

161 and 63% positivity among smear-positive and smear-negative confirmed ATB samples, respectively.

162 81% sensitivity in sputum smear-positive and smear-negative groups, respectively.

163 1.43, 3.51) and among smear-positive versus smear-negative index cases (ratio of odds ratios = 5.45,

164 , the use of CF enhanced detection of sputum smear-negative individuals.

165 HIV-seronegative patients only when they are smear-negative or lack cavitary lung disease.

166 els of empirical-evidence-based treatment in smear-negative patients.

167 ents or of M. tuberculosis isolates from AFB smear-negative samples from patients in India suspected

168 ent TB cases through targeted screening (70% smear-negative sensitivity, 85% treatment initiation) al

169 3:1 overall (80% versus 72%; P=0.03) and for smear-negative specimens (67% versus 58%; P=0.12).

170 m HIV-infected individuals, including in AFB smear-negative specimens, with 72.5% sensitivity for M.

171 is detection, with a sensitivity of 72.5% in smear-negative specimens.

172 the reporter phage was more sensitive in AFB smear-negative sputum, but specificity was lower.

173 % CI, 53.5% to 70.0%) for smear-positive and smear-negative TB, respectively, but varied widely by co

174 tra test with that of Xpert for detection of smear-negative tuberculosis and rifampicin resistance an

175 Patients with subclinical tuberculosis, smear-negative tuberculosis, extrapulmonary tuberculosis

176 of 100%, with sensitivities of 44.1% in AFB smear-negative versus 94.6% in AFB smear-positive specim

177 CI, 10%-56%) in the remaining subjects with smear-negative, culture-positive results; in this latter

178 orms of TB-including new smear-positive, new smear-negative, retreatment smear-positive, and multidru

179 During the same period, the annual number of smear-negative/culture-positive TB cases diagnosed overs

180 Comparison of the increase of smear-negative/culture-positive TB cases diagnosed overs

181 mear-based algorithm that could not diagnose smear-negative/culture-positive TB.

182 e culture-based algorithm, 2195 (54.4%) were smear-negative/culture-positive.

183 hy and collapse were closely associated with smear negativity in this age group.

184 performed RDTs (SD-Bioline) and thick blood smears on all children suspected to have malaria.

185 one-proguanil-treated patients with positive smears on day 3 was much higher (36.0%; P < .05) than th

186 Bacterial colonies were smeared onto filter paper precut to a sharp point, then

187 40 patients with fungal keratitis (positive smear or culture results or both) larger than 2 mm, invo

188 sk of placental malaria, as defined by thick smear or PCR findings, between the lopinavir/ritonavir-b

189 DNA extracts from Giemsa-stained thick blood smears or corresponding blood pellets had high sensitivi

190 X-ray (OR = 1.27, 95% CI = 1.16-1.39) or pap smear (OR = 1.16, 95% CI = 1.06-1.28), and males were mo

191 wavelength: polarization charges are always smeared out to some degree and in consequence the respon

192 subjected to very fast spectral fluctuations smearing out any possible different information from the

193 state, i.e., whether the positive charge is smeared over the molecule or localized on phenyl moiety,

194 unbiased single measurements depends on this smear parameter.

195 on of febrile children with positive malaria smears per homestead, and (b) the mean age of children w

196 Overall, none were smear positive for the sample that produced the negative

197 tive and bacteriologically confirmed (either smear positive or culture positive, or both) pulmonary t

198 World Health Organisation (WHO) estimates of smear positive TB prevalence from 1990 to 2014.

199 ch 276 (72.8%) were acid-fast bacillus (AFB) smear positive.

200 es, 7 (1.3% of smear-positive patients) were smear positive/PCR negative.

201 ients (2.5% of smear-positive patients) were smear positive/PCR negative; 8 of the 9 had a smear-posi

202 ity of 85.2% (96.7% in participants with AFB smear-positive [AFB(+)] sputum, 59.3% with AFB smear-neg

203 We identified 50 (0.2%) smear-positive and 101 (0.3%) bacteriologically confirme

204 sample design to estimate the prevalence of smear-positive and bacteriologically confirmed (either s

205 Retreatment smear-positive and MDR TB patients had poorer treatment

206 % vs. 56%) with 80% and 63% positivity among smear-positive and smear-negative confirmed ATB samples,

207 B/RIF had 100% and 81% sensitivity in sputum smear-positive and smear-negative groups, respectively.

208 d 62.0% (88/142; 95% CI, 53.5% to 70.0%) for smear-positive and smear-negative TB, respectively, but

209 Smear-positive asymptomatic infections detectable by mic

210 35 (20%) home-discharged cases were smear-positive at discharge.

211 Primary PCR identified >97% of serial smear-positive cases.

212 quality sequence data were obtained from one smear-positive culture-negative case.

213 cing data were obtained directly from all 24 smear-positive culture-positive sputa, of which 20 were

214 cal trial included patients with culture- or smear-positive filamentous fungal corneal ulcer and a ba

215 inical trial that enrolled 240 patients with smear-positive filamentous fungal corneal ulcers who enr

216 ndia that enrolled patients with culture- or smear-positive filamentous fungal corneal ulcers who had

217 cal outcomes than voriconazole treatment for smear-positive filamentous fungal keratitis, with much o

218 Patients with smear-positive filamentous fungal ulcers and visual acui

219 Smear-positive malaria was detected in 2195 of 3639 (60.

220 Groups of 15 treatment-naive, sputum smear-positive patients with pulmonary tuberculosis were

221 Nine patients (2.5% of smear-positive patients) were smear positive/PCR negativ

222 Of 722 patients with 2 samples, 7 (1.3% of smear-positive patients) were smear positive/PCR negativ

223 For new smear-positive patients, pretreatment loss to follow-up

224 The primary outcome was PCR-negative, smear-positive patients.

225 ned serial sputum samples from patients with smear-positive pulmonary TB who were consecutively enrol

226 Xinjiang survey estimates, the prevalence of smear-positive pulmonary tuberculosis has decreased by 2

227 The new smear-positive pulmonary tuberculosis notification rate

228 The weighted prevalence of smear-positive pulmonary tuberculosis was 170 (95% CI 10

229 Adults with sputum smear-positive pulmonary tuberculosis were assigned rifa

230 virus-uninfected adults with newly diagnosed smear-positive pulmonary tuberculosis were randomized to

231 is in the sputum of patients with microscopy smear-positive pulmonary tuberculosis-at eight sites in

232 ffective 4-month treatment of uncomplicated, smear-positive pulmonary tuberculosis.

233 od by using the Illumina MiSeq sequencer (40 smear-positive respiratory samples obtained after routin

234 mear positive/PCR negative; 8 of the 9 had a smear-positive result in only 1 of 3 samples, and 5 had

235 6% (95% CI, 42%-100%) in the 7 subjects with smear-positive results, and 28% (95% CI, 10%-56%) in the

236 A and gyrB genes of acid-fast bacillus (AFB) smear-positive sediments or of M. tuberculosis isolates

237 Of 323 participants with smear-positive specimens (183 men [56.7%]; 140 women [43

238 esistance detection on clinical isolates and smear-positive specimens.

239 1% in AFB smear-negative versus 94.6% in AFB smear-positive specimens.

240 This was carried out on 24 smear-positive sputum samples, collected from the United

241 tance-causing mutations in GenoLyse-treated, smear-positive sputum specimens.

242 ce were major points of attrition in the new smear-positive TB cascade.

243 Xpert for smear-positive TB had reasonable impact on MDR-TB incide

244 and 2.51 (95% CI 2.07-3.04; 40 surveys) for smear-positive TB.

245 prevalence-to-notification (P:N) ratios for smear-positive TB.

246 to 0.10] per increase of $100; p=0.0639) or smear-positive treatment success rates (-0.079% [-0.18 t

247 trospective cohort study of 85 patients with smear-positive tuberculosis and their 369 household cont

248 mplex directly in respiratory specimens from smear-positive tuberculosis cases from four different re

249 ere available for 130 (64%) of 203 recurrent smear-positive tuberculosis cases in the 13-year study p

250 tion-based retrospective cohort study on all smear-positive tuberculosis cases successfully treated b

251 ative mixing among adults with high rates of smear-positive tuberculosis contributed to transmission

252 ve cohort study, isolates from patients with smear-positive tuberculosis were subjected to drug susce

253 se in a hypothetical cohort of patients with smear-positive tuberculosis.

254 Of the 323 patients with smear-positive ulcers enrolled in MUTT-I, 299 (92.6%) we

255 tal of 2133 patients in India and Nepal with smear-positive ulcers were screened; of the 787 who were

256 ratios = 2.24, 95% CI: 1.43, 3.51) and among smear-positive versus smear-negative index cases (ratio

257 ar-positive, new smear-negative, retreatment smear-positive, and multidrug-resistant (MDR) TB.

258 omly assigned patients with newly diagnosed, smear-positive, drug-sensitive tuberculosis to one of th

259 assigned 160 patients with newly diagnosed, smear-positive, multidrug-resistant tuberculosis to rece

260 ents with specific forms of TB-including new smear-positive, new smear-negative, retreatment smear-po

261 nvolving patients 18 to 65 years of age with smear-positive, rifampin-sensitive, newly diagnosed pulm

262 ed respiratory isolation for patients having smear-positive/MTD-negative/culture-negative specimens,

263 decreased time to diagnosis in patients with smear-positive/MTD-positive specimens, decreased respira

264 Nevertheless, the occurrence of smear-positive/PCR-negative cases underlines the importa

265 nfiltration has significant association with smear positivity in childhood tuberculosis.

266 lar infiltration were highly associated with smear positivity in children.

267 tection window from a maximum of 14 days for smear positivity to 30 days for PCR.

268 Frequency of CSF acid-fast-bacilli smear positivity was 8.9% (95% CI 5.0-15.4), and frequen

269 e cutoff of 28 had good predictive value for smear positivity.

270 rculin skin test of the contacts, as well as smear-positivity, residence in high-incidence areas, and

271 he process, including poor specimen quality, smear preparation, and interpretation of the smears.

272 ear with a value of 48M-71M USD for a sputum smear-replacement test; (2) 16M tests/year with a value

273 These smears represent a potential source of DNA for PCR testi

274 pattern, previous treatment history, sputum smear result, and extent of disease on chest radiograph.

275 into 2 groups based on positive and negative smear results.

276 A peripheral blood smear revealed anemia, thrombocytopenia, and blast cells

277 er investigation using real patient cervical smear sample for a non-invasive, ultrafast and accurate

278 ients tested by clinical human biopsy or pap smear samples.

279 2 US health plans, we compared Papanicolaou smear screening histories of women aged 55-79 years who

280 ning for cervical cancer with a Papanicolaou smear, screening for gonorrhea and chlamydia).

281 les were obtained for direct fluorescent AFB smear, SMF, Xpert MTB/RIF, and MGIT culture media.

282 In this work we examine how nonlinearity can smear statistical photon bunching in the HOM interferome

283 ung disease (P < 0.0001 for interaction) and smear status (P = 0.02 for interaction) of tuberculosis

284 lture positivity was similar to that between smear status and time to culture positivity (both Spearm

285 be used as a measure of bacterial burden and smear status in a high HIV burden setting.

286 hen parasitaemic, as detected by thick blood smear (TBS) microscopy.

287 method performed poorly compared to standard smear techniques and was sensitive to sample preparation

288 A logit model identified young age, positive smear test, and lower Index of Quality of Urban Municipa

289 ients with positive result from standard Pap smear test, indicating that an electrochemical immunosen

290 Among patients with positive blood smears, the quick diagnostic test was positive in 33 of

291 s, these two transitions become increasingly smeared together, so measuring a clear distinction betwe

292 dium and Babesia species on peripheral blood smears utilizing the CellaVision DM96 with the rates for

293 While a positive 2-month smear was not significantly associated with an unsuccess

294 In the absence of discharge, meatal smears were associated with a significant reduction in c

295 ia and Burkina Faso, RDT cassettes and blood smears were re-read by an experienced investigator at st

296 ith single MS scans of necrotic tumor tissue smears, which further accelerates the identification wor

297 l vertebrate carcasses, which they shave and smear with antimicrobial exudates.

298 ing of biodegradation of hydrocarbons in the smear zone.

299 Smear zones that contained both LNAPL residual and trapp

300 t from light nonaqueous phase liquid (LNAPL) smear zones.